CD274 and esophageal cancer: Previous studies of ICIs with first-line chemotherapy in patients with advanced esophageal cancer and gastroesophageal junction cancer have demonstrated that survival benefits were enhanced in patients of high PD-L1 expression level according to CPS (34, 35).